Submicroscopic deletion of chromosome 16p13.3 in patients with Rubinstein-Taybi syndrome

Am J Med Genet. 1998 Jul 7;78(3):267-70.


The Rubinstein-Taybi syndrome (RTS) is a well-defined entity characterized by growth and mental retardation, broad thumbs and halluces, and typical face. The RTS locus was assigned to 16p13.3, and interstitial submicroscopic deletions of this region (RT1 cosmid, D16S237) were initially identified in 25% of RTS patients. The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients. We investigated 30 French patients with RTS. Among these patients, 3 had the RT1 microdeletion (frequency 10%). There is no obvious phenotypic difference between the patients with and without the RT1 deletion. The RT1 probe appears useful for confirmation of the diagnosis but is of little interest as a screening tool. By pooling data including the previous series and our current series, the cumulative frequency of the 16p13.3 microdeletion is 11.9% (19 in 159). This frequency of approximately 12% deleted patients appears more accurate than the 25% previously reported. Molecular investigations of CBP are in process in our series to clarify the cause of RTS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CREB-Binding Protein
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 16 / genetics*
  • Cosmids
  • DNA Probes
  • Female
  • France
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Male
  • Mutation
  • Nuclear Proteins / genetics*
  • Rubinstein-Taybi Syndrome / genetics*
  • Trans-Activators / genetics*


  • DNA Probes
  • Nuclear Proteins
  • Trans-Activators
  • CREB-Binding Protein
  • CREBBP protein, human